DIET/NUTRIENT INTERACTIONS WITH DRUG TRANSPORTERS - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 697

2. Anderson KE. 1998. Influences of diet and nutrition on clinical pharmacokinetics. Clin
Pharmacokinet 14(6):325-346.
3. Evans AM. 2000. Influence of dietary components on the gastrointestinal metabolism
and transport of drugs. Ther Drug Monit 22(1):131-136.
4. Harris RZ, Jang GR, Tsunoda S. 2003. Dietary effects on drug metabolism and transport.
Clin Pharmacokinet 42(13):1071-1088.
5. Walter-Sack I, Klotz U. 1996. Influence of diet and nutritional status on drug metabolism.
Clin Pharmacokinet 31(1):47-64.
6. Ioannides C. 2002. Pharmacokinetic interactions between herbal remedies and medicinal
drugs. Xenobiotica 32(6):451-478.
7. Ohnishi N, Yokoyama T. 2004. Interactions between medicines and functional foods or
dietary supplements. Keio J Med 53(3):137-150.
8. Kim RB. 2002. Transporters and xenobiotic disposition. Toxicology 181-182:291-297.
9. Ho RH, Kim RB. 2005. Transporters and drug therapy: implications for drug disposition
and disease. Clin Pharmacol Ther 78(3):260-277.
10. Beringer PM, Slaughter RL. 2005. Transporters and their impact on drug disposition.
Ann Pharmacother 39(6):1097-1108.
11. Leslie EM, Deeley RG, Cole SP. 2005. Multidrug resistance proteins: role of P-
glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Phar-
macol 204(3):216-237.
12. Hagenbuch B, Meier PJ. 2004. Organic anion transporting polypeptides of the
OATP/SLC21 family: phylogenetic classification as OATP/ SLCO superfamily,
new nomenclature and molecular/functional properties. Pflugers Arch 447(5):653-
665.
13. You G. 2004. Towards an understanding of organic anion transporters: structure-function
relationships. Med Res Rev 24(6):762-774.
14. Koepsell H, Schmitt BM, Gorboulev V. 2003. Organic cation transporters. Rev Physiol
Biochem Pharmacol 150:36-90.
15. Allen JD, Schinkel AH. 2002. Multidrug resistance and pharmacological protection medi-
ated by the breast cancer resistance protein (BCRP/ABCG2). Mol Cancer Ther 1(6):427-
434.
16. Borst P, Evers R, Kool M, Wijnholds J. 2000. A family of drug transporters: the multidrug
resistance-associated proteins. J Natl Cancer Inst 92(16):1295-1302.
17. K onig J, Nies AT, Cui Y, Leier I, Keppler D. 1999. Conjugate export pumps of the
multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-
mediated drug resistance. Biochim Biophys Acta 1461(2):377-394.
18. Litman T, Druley TE, Stein WD, Bates SE. 2001. From MDR to MXR: new understanding
of multidrug resistance systems, their properties and clinical significance. Cell Mol Life
Sci 58(7):931-959.
19. Gottesman MM, Pastan I. 1993. Biochemistry of multidrug resistance mediated by the
multidrug transporter. Annu Rev Biochem 62:385-427.
20. Leonard GD, Fojo T, Bates SE. 2003. The role of ABC transporters in clinical practice.
Oncologist 8(5):411-424.
21. Doyle LA, Ross DD. 2003. Multidrug resistance mediated by the breast cancer resistance
protein BCRP (ABCG2). Oncogene 22(47):7340-7358.